Fig. 3From: Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysisThe pooled rates of bleeding (a) and the pooled MDs of total bilirubin (b), pH (c), and serum bicarbonate (d) between the start of CRRT and the end of observation. CI, confidence interval; G1 group 1, G2 group 2, G3 group 3, G4 group 4; MD, mean difference; M, mild liver failure group; S, Severe liver failure groupBack to article page